Why the study?
Whether individuals with metabolically healthy obesity have an increased risk of CVD is controversial, potentially due to differences in how MHO is defined.
Does the presence of Metabolic Syndrome risk factors increase the risk of incident cardiovascular disease in overweight and obese men?
Does the presence of Metabolic Syndrome risk factors increase the risk of incident cardiovascular disease in overweight and obese men?
The risk of cardiovascular disease in obesity is highly dependent on the presence of metabolic syndrome risk factors, with truly 'metabolically healthy' obesity being extremely rare but not associated with increased risk.
Answers are grounded in this paper and cite their sources.
Definition-dependent MHO-CVD risk estimates warrant caution in phenotyping; leaves open whether any truly benign obese subgroup exists.
Background: Whether subjects with metabolically healthy obesity (MHO) have an increased risk of cardiovascular disease (CVD) is controversial. Some of this discrepancy could be due to differences in the definition of MHO. Therefore, we investigated how the definition of MHO affected the risk of CVD. Methods: In the Uppsala Longitudinal Study of Adult Men (ULSAM) cohort (total n = 2122, mean age 50 years), obese (n = 134), overweight (n = 845), and normal weight (n = 1143) individuals were subdivided according to the number of Metabolic Syndrome (MetS) risk factors (excluding waist circumference). During a median follow-up of 28.0 years, 877 individuals experienced a CVD event (defined as fatal or nonfatal myocardial infarction, stroke, or heart failure). Results: All obese groups, except that without any MetS risk factors (n = 3), showed an increased risk compared to the control group of normal weight without any MetS risk factors (n = 235), ranging from a hazard ratio (HR) of 3.0 (95% confidence interval [CI] 1.7–5.3, P = 0.0002) in those with one MetS risk factor to HR 5.5 (95% CI 3.0–9.8, P < 0.00001) in those with four MetS risk factors. The overweight group without any MetS risk factor (n = 74) showed a similar risk of incident CVD as the normal weight group, whereas all other overweight groups showed an increased risk with increasing number of MetS risk factors. Conclusions: The results suggest that the definition of MHO played a major role on the risk of CVD. No increased risk was seen in overweight/obese individuals with no MetS risk factor, but they were very rare.
No takes yet. Share an insight, caveat, or question.
Lind et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: